Overview Myomectomy (my-o-MEK-tuh-me) is a surgical procedure to remove uterine fibroids — also called leiomyomas (lie-o-my-O-muhs). These common noncancerous growths appear in the uterus. Uterine fibroids usually develop during childbearing years, but they can occur at any age. The surgeon’s goal during myomectomy is to take out symptom-causing fibroids and reconstruct the uterus. Unlike a […]
Myomectomy (my-o-MEK-tuh-me) is a surgical procedure to remove uterine fibroids — also called leiomyomas (lie-o-my-O-muhs). These common noncancerous growths appear in the uterus. Uterine fibroids usually develop during childbearing years, but they can occur at any age.
The surgeon’s goal during myomectomy is to take out symptom-causing fibroids and reconstruct the uterus. Unlike a hysterectomy, which removes your entire uterus, a myomectomy removes only the fibroids and leaves your uterus.
Women who undergo myomectomy report improvement in fibroid symptoms, including decreased heavy menstrual bleeding and pelvic pressure.
Why it’s done
Your doctor might recommend myomectomy for fibroids causing symptoms that are troublesome or interfere with your normal activities. If you need surgery, reasons to choose a myomectomy instead of a hysterectomy for uterine fibroids include:
- You plan to bear children
- Your doctor suspects uterine fibroids might be interfering with your fertility
- You want to keep your uterus
Outcomes from myomectomy may include:
- Symptom relief. After myomectomy surgery, most women experience relief of bothersome signs and symptoms, such as excessive menstrual bleeding and pelvic pain and pressure.
- Fertility improvement. Women who undergo laparoscopic myomectomy, with or without robotic assistance, have good pregnancy outcomes within about a year of surgery. After a myomectomy, suggested waiting time is three to six months before attempting conception to allow your uterus time to heal.
Fibroids that your doctor doesn’t detect during surgery or fibroids that are not completely removed could eventually grow and cause symptoms. New fibroids, which may or may not require treatment, can also develop. Women who had only one fibroid have a lower risk of developing new fibroids — often termed the recurrence rate — than do women who had multiple fibroids. Women who become pregnant after surgery also have a lower risk of developing new fibroids than women who don’t become pregnant.
Women who have new or recurring fibroids may have additional, nonsurgical treatments available to them in the future. These include:
- Uterine artery embolization (UAE). Microscopic particles are injected into one or both uterine arteries, limiting blood supply.
- Radiofrequency volumetric thermal ablation (RVTA). Radiofrequency energy is used to wear away (ablate) fibroids using friction or heat — for instance, guided by an ultrasound probe.
- MRI-guided focused ultrasound surgery (MRgFUS). A heat source is used ablate fibroids, guided by magnetic resonance imaging (MRI).
Some women with new or recurring fibroids may choose a hysterectomy if they have completed childbearing